Public Profile

Green Cross Holdings Corporation

Green Cross Holdings Corporation, headquartered in South Korea (KR), is a prominent player in the biopharmaceutical industry. Founded in 1967, the company has established itself as a leader in the development and production of innovative vaccines, blood products, and biopharmaceuticals. With a strong focus on research and development, Green Cross Holdings has achieved significant milestones, including the successful launch of various life-saving therapies. The company operates primarily in the Asia-Pacific region, with a commitment to enhancing public health through its core offerings, which include immunoglobulins and vaccines. What sets Green Cross apart is its dedication to quality and safety, ensuring that its products meet the highest international standards. Recognised for its contributions to healthcare, Green Cross Holdings continues to strengthen its market position, making strides in both domestic and global markets.

DitchCarbon Score

How does Green Cross Holdings Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Green Cross Holdings Corporation's score of 22 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Green Cross Holdings Corporation's reported carbon emissions

Green Cross Holdings Corporation, headquartered in South Korea (KR), currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the industry are increasingly focusing on sustainability and climate commitments, often setting ambitious targets to reduce their carbon footprint. Green Cross Holdings Corporation may be engaging in similar initiatives, but specific details are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Green Cross Holdings Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Green Cross Holdings Corporation is in KR, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Green Cross Holdings Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Adimmune Corporation

TW
Health and social work services (85)
Updated 24 days ago

Jcr Pharmaceuticals

JP
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers